Invesco’s Protalix BioTherapeutics PLX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $66.8K | Buy |
+45,141
| New | +$66.8K | ﹤0.01% | 3698 |
|
|
2024
Q2 | – | Sell |
-25,908
| Closed | -$32.6K | – | 3934 |
|
|
2024
Q1 | $32.6K | Sell |
25,908
-976
| -4% | -$1.23K | ﹤0.01% | 3812 |
|
|
2023
Q4 | $47.9K | Sell |
26,884
-29,531
| -52% | -$52.6K | ﹤0.01% | 3743 |
|
|
2023
Q3 | $93.6K | Buy |
56,415
+34,763
| +161% | +$57.7K | ﹤0.01% | 3711 |
|
|
2023
Q2 | $43.3K | Buy |
+21,652
| New | +$43.3K | ﹤0.01% | 3810 |
|
|
2019
Q1 | – | Sell |
-35,959
| Closed | -$11K | – | 3733 |
|
|
2018
Q4 | $11K | Sell |
35,959
-1,330
| -4% | -$407 | ﹤0.01% | 3717 |
|
|
2018
Q3 | $27K | Sell |
37,289
-5,643
| -13% | -$4.09K | ﹤0.01% | 3789 |
|
|
2018
Q2 | $18K | Buy |
+42,932
| New | +$18K | ﹤0.01% | 3801 |
|